Sarkany Z, Damasio J, Macedo-Ribeiro S, Martins PM, et al. Reply to "Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent". Alzheimers Dement 2025;21:e70533.
PMID: 40696846